How Big Is the Cell Therapy Market | Industry Trends & Forecast 2025

Q: What is the current size and forecast of the global cell therapy market?

The market was valued at USD 11.2 billion in 2024 and is projected to reach USD 32.7 billion by 2031 at a CAGR of 16.5%.

Q: Which areas are leading in adoption?

Oncology, autoimmune diseases, and regenerative medicine lead adoption globally.

Q: What’s driving the demand?

Personalized treatments, rapid R&D, and wider regulatory support are key demand drivers.

Q: What challenges does the industry face?

Manufacturing complexity, regulatory hurdles, cost of therapy, and scalability remain key concerns.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA4766

Publication Date: Jul 2025

How big is the Cell Therapy Market?

According to 6Wresearch internal database and industry insights, the Global Cell Therapy market was valued at approximately USD 11.2 billion in 2024 and is projected to reach USD 32.7 billion by 2031, growing at a CAGR of 16.5% during the forecast period.

This growth is fueled by rising approvals of advanced therapies, expanding applications in oncology and autoimmune diseases, and growing investments in personalized medicine.

Key Growth Drivers of the Cell Therapy Market

FDA approvals of CAR-T and stem cell-based therapies across multiple indications
Expanding cell therapy pipelines for oncology, neurology, and orthopedics
Surge in funding and partnerships from pharmaceutical and biotech companies
Rapid innovation in gene editing, cryopreservation, and cell expansion technologies
Shift toward autologous and allogeneic therapies with scalable clinical models

Cell Therapy Market Trends

Cell therapy market is witnessing growing integration with gene therapy and regenerative medicine. Autologous treatments are expanding for rare and relapsed cancers, while allogeneic therapies are gaining ground for scalable commercial use. Technologies like CRISPR-Cas9 and AI-based cell identification are reshaping therapy design. Hospitals and clinics are partnering with CDMOs and research centers for clinical-grade processing and delivery. The globalization of cell therapy trials is also accelerating.

Emerging Developments in the Cell Therapy Market

New frontiers are in vivo gene-modified cell therapies and ready-made NK and T-cell therapies. The number of patients being monitored remotely by using digital health tools and the number of patients being dosed individually by using digital health tools is growing. The generation of AI-based algorithms is being trained to currently optimize choice of cells and ability of potency prediction. There is a shift towards decentralized modes of producing utilizing portable cleanrooms. Also, national biomanufacturing centers are being invested in by the governments so as to enhance clinical and commercial scale up.